Senseonics Holdings, Inc. (SENS) États Financiers et Données Historiques

Senseonics Holdings, Inc. (SENS) — Prix $9.06 HealthcareMedical - Devices — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Senseonics Holdings, Inc. (SENS): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Senseonics Holdings, Inc. a enregistré un chiffre d'affaires de $35.3M sur le dernier exercice, avec un CAGR sur 5 ans de 48.1%.

Marges des 12 derniers mois: marge brute 54.9%, marge opérationnelle -223.2%, marge nette -225.3%.

Au prix actuel de $9.06, SENS affiche des résultats négatifs (PER non significatif) et un ROE de -113.21%. La capitalisation boursière s'établit à $379M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$332000$6.4M$18.9M$21.3M$4.9M$13.7M$16.4M$22.4M$22.5M$35.3M
Coût des Ventes$660000$9.8M$27.1M$40.7M$22.3M$14.5M$13.7M$19.3M$21.9M$19.5M
Marge Brute-$328000-$3.4M-$8.1M-$19.4M-$17.4M-$811000$2.7M$3.1M$533000$15.8M
R&D$26.3M$30.7M$31.9M$38.4M$20.4M$27.2M$39.7M$48.8M$41.1M$31.6M
Frais Généraux$15.8M$22.2M$47.6M$72.8M$41.4M$29.2M$31.6M$29.9M$34.2M$52.5M
Charges Opérationnelles$42.1M$52.9M$79.4M$111.2M$61.8M$56.4M$71.4M$78.7M$75.4M$84.1M
Résultat Opérationnel-$42.4M-$56.3M-$87.6M-$130.7M-$79.1M-$57.2M-$68.6M-$75.6M-$74.8M-$68.3M
EBITDA-$42.2M-$55.8M-$85.4M-$99.4M-$157.9M-$284.5M$161.8M-$48.0M-$68.7M-$62.6M
Charges d'Intérêt$1.6M$3.1M$8.3M$15.1M$16.2M$16.7M$18.7M$11.1M$8.4M$5.0M
Résultat Avant Impôts-$43.9M-$59.1M-$94.0M-$115.5M-$175.2M-$302.5M$142.1M-$60.4M-$78.6M-$69.1M
Impôts0000000000
Résultat Net-$43.9M-$59.1M-$94.0M-$115.5M-$175.2M-$302.5M$142.1M-$60.4M-$78.6M-$69.1M
BPA$-9.80$-10.20$-12.00$-12.20$-15.40$-14.40$6.07$-2.20$-2.50$-1.66
BPA Dilué$-9.80$-10.20$-12.00$-12.20$-15.40$-14.40$-2.17$-2.20$-2.50$-1.66
Actions en Circulation (Diluées)$4.5M$5.8M$7.9M$9.4M$11.4M$21.1M$30.9M$28.4M$31.5M$41.7M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$8.1M$14.3M$11.7M$14.5M
Marge Brute$3.5M$7.7M$6.9M$8.6M
Résultat Opérationnel-$19.6M-$20.9M-$31.8M-$36.0M
EBITDA-$18.0M-$19.2M-$30.6M-$34.6M
Résultat Net-$19.5M-$20.8M-$32.3M-$36.7M
BPA$-0.43$-0.50$-0.71$-0.63
BPA Dilué$-0.43$-0.50$-0.71$-0.63

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$13.0M$16.1M$136.8M$95.9M$18.0M$33.5M$35.8M$75.7M$74.6M$40.5M
Placements à Court Terme$7.3M$20.3M000$96.4M$108.2M$33.7M0$53.8M
Créances$251000$3.4M$7.1M$10.5M$3.0M$2.4M$2.8M$6.6M$8.1M$12.4M
Stocks$477000$3.0M$10.2M$16.9M$5.3M$6.3M$7.3M$8.8M$4.4M$6.7M
Actifs Courants$21.4M$44.9M$158.1M$127.8M$30.2M$144.4M$161.2M$130.0M$91.4M$117.5M
Immobilisations Corporelles$735000$853000$1.8M$2.0M$1.6M$1.3M$1.1M$1.2M$3.6M$4.2M
Goodwill0000000000
Actifs Incorporels00000000$481920$800000
Actifs Totaux$22.3M$45.9M$160.0M$132.8M$35.9M$198.9M$177.7M$138.2M$100.4M$126.3M
Dettes Fournisseurs$3.1M$7.7M$4.4M$4.3M$1.8M$1.2M$419000$4.6M$3.2M$4.1M
Dette à Court Terme$3.9M$10.0M$10.0M$103.8M$3.2M$2.9M$15.6M0$20.1M$496000
Passifs Courants$11.6M$23.1M$28.9M$126.7M$16.6M$18.4M$31.5M$17.3M$38.8M$24.3M
Dette à Long Terme$15.2M$14.4M$41.0M$11.8M$57.2M$59.8M$56.4M$41.2M$34.7M$35.6M
Passifs Totaux$27.1M$38.7M$88.7M$141.4M$180.0M$384.5M$180.2M$102.4M$117.0M$65.2M
Réserves-$204.7M-$263.8M-$357.8M-$473.3M-$648.5M-$951.0M-$808.9M-$869.3M-$947.9M-$1.02B
Capitaux Propres-$4.9M$7.3M$71.3M-$8.6M-$144.1M-$185.5M-$2.6M$35.8M-$16.6M$61.0M
Dette Totale$19.2M$24.5M$51.0M$118.6M$62.7M$64.2M$75.4M$47.8M$61.1M$41.4M
Dette Nette-$1.1M-$12.0M-$85.8M$22.6M$44.7M-$65.7M-$68.6M-$61.7M-$13.5M-$52.7M
Fonds de Roulement$9.8M$21.8M$129.2M$1.1M$13.6M$126.0M$129.7M$112.8M$52.6M$93.2M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$34.8M$40.5M$29.9M$44.8M
Actifs Totaux$139.9M$126.3M$102.9M$176.8M
Passifs Totaux$61.8M$65.2M$68.5M$86.5M
Capitaux Propres$78.2M$61.0M$34.3M$90.3M
Dette Totale$41.2M$41.4M$43.1M$61.8M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$43.9M-$59.1M-$94.0M-$115.5M-$175.2M-$302.5M$142.1M-$60.4M-$78.6M-$69.1M
Amortissements$155000$227000$270000$1.0M$1.1M$1.2M$985000$1.3M$1.5M$91000
Stock-based Compensation$2.4M$4.0M$6.4M$8.1M$7.3M$9.0M$8.6M$8.7M$9.2M$10.2M
Variation du BFR$2.7M-$1.4M-$6.7M-$9.5M$13.8M-$1.5M-$2.5M-$4.0M$865000-$3.3M
Cash Flow Opérationnel-$38.0M-$55.7M-$90.8M-$136.0M-$67.4M-$56.1M-$66.3M-$70.2M-$60.5M-$59.1M
CapEx-$479000-$345000-$989000-$1.0M-$181000-$210000-$312000-$350000-$2.2M-$1.1M
Acquisitions00000$210000-$27.2M000
Rachat d'Actions0000-$2600000000
Dividendes Payés0000000000
Free Cash Flow-$38.5M-$56.1M-$91.8M-$137.1M-$67.6M-$56.3M-$66.6M-$70.5M-$62.7M-$60.2M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$15.8M-$18.0M-$32.0M-$30.1M
CapEx-$164000-$394000-$111000-$217000
Free Cash Flow-$16.0M-$18.4M-$32.1M-$30.4M
Dividendes Payés0000
Stock-based Compensation$2.8M$2.6M$2.3M$3.6M

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+1819.6%+196.8%+12.6%-76.8%+176.3%+19.8%+36.6%+0.4%+56.9%
Croissance Résultat Net (annuelle)-34.5%-59.0%-23.0%-51.6%-72.7%+147.0%-142.5%-30.2%+12.1%
Croissance BPA (annuelle)-4.1%-17.6%-1.7%-26.2%+6.5%+142.2%-136.2%-13.6%+33.6%
Variation Actions (annuelle)+30.0%+35.7%+19.9%+20.7%+85.3%+46.4%-8.1%+10.9%+32.5%
Croissance FCF (annuelle)-45.7%-63.6%-49.4%+50.7%+16.7%-18.4%-5.8%+11.1%+3.9%
Marge Brute-98.8%-53.1%-43.1%-91.3%-350.9%-5.9%16.6%13.8%2.4%44.7%
Marge Opérationnelle-12781.0%-883.6%-463.1%-613.4%-1598.9%-418.1%-418.7%-337.7%-333.0%-193.8%
Marge EBITDA-12702.7%-875.2%-451.6%-466.7%-3189.7%-2080.5%987.3%-214.4%-305.7%-177.7%
Marge Nette-13231.9%-927.4%-496.9%-542.5%-3539.5%-2211.9%867.2%-269.7%-349.8%-196.0%
Marge FCF-11594.9%-880.0%-485.2%-643.6%-1366.0%-411.6%-406.5%-314.9%-279.0%-170.9%
Taux d'Imposition Effectif-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-8.63$-9.67$-11.66$-14.53$-5.93$-2.67$-2.16$-2.48$-1.99$-1.44
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$4.5M$5.8M$7.9M$9.4M$11.4M$21.1M$23.4M$28.4M$31.5M$41.7M

Quoi regarder en Santé / Pharma

Le pipeline R&D est l'actif invisible. Brevets qui expirent = revenus qui s'évaporent. Regardez innovation et cash flow.

Rentabilité

Rentabilité des capitaux propres-113.21%
Rentabilité du capital investi-66.72%
Rentabilité des actifs-54.73%
Marge brute54.87%
Marge opérationnelle-223.22%
Marge nette-225.34%

Santé financière

Dette / Capitaux propres0.68
Ratio de liquidité6.74

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-5.45-5.22-4.32-1.50-1.13-3.713.39-5.18-4.19-3.33
P/B-48.8642.455.72-19.99-1.38-6.08-187.119.04-19.913.77
P/V717.7248.4121.568.1240.1682.4629.4114.4614.676.53
Marge Brute-98.8%-53.1%-43.1%-91.3%-350.9%-5.9%16.6%13.8%2.4%44.7%
Marge Opérationnelle-12781.0%-883.6%-463.1%-613.4%-1598.9%-418.1%-418.7%-337.7%-333.0%-193.8%
Marge Nette-13231.9%-927.4%-496.9%-542.5%-3539.5%-2211.9%867.2%-269.7%-349.8%-196.0%

Entreprises liées: ACRS · CAPR · CERS · CVRX · MASS · NNOX · NPCE

Explorer le secteur: Healthcare · Medical - Devices

Plus de sections de SENS: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions